Literature DB >> 28584041

Primary aldosteronism: a common cause of resistant hypertension.

Gregory A Kline1, Ally P H Prebtani2, Alexander A Leung2, Ernesto L Schiffrin2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28584041      PMCID： PMC5461126          DOI： 10.1503/cmaj.161486

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  61 in total

1.  Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio.

Authors:  B J Gallay; S Ahmad; L Xu; B Toivola; R C Davidson
Journal:  Am J Kidney Dis       Date:  2001-04       Impact factor: 8.860

2.  Hyperaldosteronism among black and white subjects with resistant hypertension.

Authors:  David A Calhoun; Mari K Nishizaka; Mohammad A Zaman; Roopal B Thakkar; Paula Weissmann
Journal:  Hypertension       Date:  2002-12       Impact factor: 10.190

Review 3.  Aberrant hormone receptors in primary aldosteronism.

Authors:  T L Mazzuco; S Grunenwald; A Lampron; I Bourdeau; A Lacroix
Journal:  Horm Metab Res       Date:  2010-01-07       Impact factor: 2.936

4.  High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.

Authors:  Michael Stowasser; Richard D Gordon; Thanuja G Gunasekera; Diane C Cowley; Gregory Ward; Colin Archibald; B Mark Smithers
Journal:  J Hypertens       Date:  2003-11       Impact factor: 4.844

5.  Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan.

Authors:  Masao Omura; Jun Saito; Kunio Yamaguchi; Yukio Kakuta; Tetsuo Nishikawa
Journal:  Hypertens Res       Date:  2004-03       Impact factor: 3.872

6.  Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.

Authors:  Paolo Mulatero; Michael Stowasser; Keh-Chuan Loh; Carlos E Fardella; Richard D Gordon; Lorena Mosso; Celso E Gomez-Sanchez; Franco Veglio; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

7.  Medical or surgical therapy for primary aldosteronism: post-treatment follow-up as a surrogate measure of comparative outcomes.

Authors:  G A Kline; J L Pasieka; A Harvey; B So; V C Dias
Journal:  Ann Surg Oncol       Date:  2013-03-16       Impact factor: 5.344

8.  Chronic kidney disease score for predicting postoperative masked renal insufficiency in patients with primary aldosteronism.

Authors:  Kanako Tanase-Nakao; Mitsuhide Naruse; Kazutaka Nanba; Mika Tsuiki; Tetsuya Tagami; Takeshi Usui; Hiroshi Okuno; Akira Shimatsu; Shigeatsu Hashimoto; Takuyuki Katabami; Atsushi Ogo; Ataru Okumura; Hironobu Umakoshi; Tomoko Suzuki
Journal:  Clin Endocrinol (Oxf)       Date:  2014-06-12       Impact factor: 3.478

9.  Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism.

Authors:  Gian Paolo Rossi; Maurizio Cesari; Cesare Cuspidi; Giuseppe Maiolino; Maria Verena Cicala; Valeria Bisogni; Franco Mantero; Achille C Pessina
Journal:  Hypertension       Date:  2013-05-06       Impact factor: 10.190

10.  Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry.

Authors:  E Born-Frontsberg; M Reincke; L C Rump; S Hahner; S Diederich; R Lorenz; B Allolio; J Seufert; C Schirpenbach; F Beuschlein; M Bidlingmaier; S Endres; M Quinkler
Journal:  J Clin Endocrinol Metab       Date:  2009-02-03       Impact factor: 5.958
View more
  10 in total

1.  Is aldosteronism really a relatively common cause of hypertension?

Authors:  Günther Egidi; Guido Schmiemann; Klaus Gebhardt
Journal:  CMAJ       Date:  2018-04-03       Impact factor: 8.262

2.  [Clinical value of captopril test in noninvasive diagnosis of aldosterone-producing adenoma].

Authors:  B Dong; X W Ma; X H Guo; Y Gao; J Q Zhang
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2021-12-18

3.  Brazilian Position Statement on Resistant Hypertension - 2020.

Authors:  Juan Carlos Yugar-Toledo; Heitor Moreno Júnior; Miguel Gus; Guido Bernardo Aranha Rosito; Luiz César Nazário Scala; Elizabeth Silaid Muxfeldt; Alexandre Alessi; Andrea Araújo Brandão; Osni Moreira Filho; Audes Diógenes de Magalhães Feitosa; Oswaldo Passarelli Júnior; Dilma do Socorro Moraes de Souza; Celso Amodeo; Weimar Kunz Sebba Barroso; Marco Antônio Mota Gomes; Annelise Machado Gomes de Paiva; Eduardo Costa Duarte Barbosa; Roberto Dischinger Miranda; José Fernando Vilela-Martin; Wilson Nadruz Júnior; Cibele Isaac Saad Rodrigues; Luciano Ferreira Drager; Luiz Aparecido Bortolotto; Fernanda Marciano Consolim-Colombo; Márcio Gonçalves de Sousa; Flávio Antonio de Oliveira Borelli; Sérgio Emanuel Kaiser; Gil Fernando Salles; Maria de Fátima de Azevedo; Lucélia Batista Neves Cunha Magalhães; Rui Manoel Dos Santos Póvoa; Marcus Vinícius Bolívar Malachias; Armando da Rocha Nogueira; Paulo César Brandão Veiga Jardim; Thiago de Souza Veiga Jardim
Journal:  Arq Bras Cardiol       Date:  2020 May-Jun       Impact factor: 2.000

Review 4.  Associations between primary aldosteronism and diabetes, poor bone health, and sleep apnea-what do we know so far?

Authors:  Huai Heng Loh; Norlela Sukor
Journal:  J Hum Hypertens       Date:  2019-12-10       Impact factor: 3.012

Review 5.  Vascular Mineralocorticoid Receptor: Evolutionary Mediator of Wound Healing Turned Harmful by Our Modern Lifestyle.

Authors:  Lauren A Biwer; Mary C Wallingford; Iris Z Jaffe
Journal:  Am J Hypertens       Date:  2019-01-15       Impact factor: 2.689

Review 6.  Progress in the Management of Primary Aldosteronism.

Authors:  Ryo Morimoto; Kei Omata; Sadayoshi Ito; Fumitoshi Satoh
Journal:  Am J Hypertens       Date:  2018-04-13       Impact factor: 2.689

7.  The Quality of Clinical Practice Guidelines and Consensuses on the Management of Primary Aldosteronism: A Critical Appraisal.

Authors:  Zhe Meng; Liang Zhou; Zhe Dai; Chang Xu; Guofeng Qian; Mou Peng; Yuchun Zhu; Joey S W Kwong; Xinghuan Wang
Journal:  Front Med (Lausanne)       Date:  2020-05-05

8.  Developing an ultra-performance liquid chromatography-tandem mass spectrometry for detecting aldosterone in human plasma.

Authors:  Wenbin Lin; Zhenrong Yao; Yuzhe Li; Zhihao Liao; Jiahao Xiao; Yonghong Chen; Pinning Feng; Wenjia Gan
Journal:  J Clin Lab Anal       Date:  2021-09-30       Impact factor: 2.352

9.  Surgical Outcomes of Aldosterone-Producing Adenoma on the Basis of the Histopathological Findings.

Authors:  Huiping Wang; Fen Wang; Yushi Zhang; Jin Wen; Dexin Dong; Xiaoyan Chang; Hao Sun; Xiaosen Ma; Yunying Cui; Shi Chen; Lin Lu; Weidong Ren; Anli Tong; Yuxiu Li
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-06       Impact factor: 5.555

10.  Online prediction model for primary aldosteronism in patients with hypertension in Chinese population: A two-center retrospective study.

Authors:  Wenbin Lin; Wenjia Gan; Pinning Feng; Liangying Zhong; Zhenrong Yao; Peisong Chen; Wanbing He; Nan Yu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-02       Impact factor: 6.055
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.